Patients with cancer having COPD have worse survival than those without COPD [43,44,45,46,47] because COPD increases C-reactive protein levels, a biomarker of systemic inflammation, which is associated with an increased risk of cancer mortality, including for extrapulmonary cancers [47]. Here, CRP is linked to cancer.